ESMO 2020 Conference Highlights eBOOK
ESMO 2020 Lung Cancer Conference Report In Focus: Lung Cancer Durvalumab Demonstrates...
Dec 23, 2020
ESMO 2020 Lung Cancer Conference Report In Focus: Lung Cancer Durvalumab Demonstrates...
Sep 24, 2020
Several clinical trials have showed that combining an anti-CTLA-4 inhibitor and an anti-PD-(L)1...